Attorney Profile

York is a veteran trial lawyer with more than 30 years’ experience handling high- stakes litigation, trying cases to verdict in numerous jury and bench trials.

​

York began his career as a federal prosecutor in the U.S. Department of Justice, Tax Division, conducting grand jury investigations and obtaining convictions at trial on such charges as obstruction of justice, conspiracy to defraud the IRS, tax evasion, false claims for tax refunds, and filing false income tax returns.

​

In civil practice, York’s work has focused on intellectual property litigation across a variety of industries with a career focus on representing brand companies in “Hatch-Waxman” pharmaceutical patent infringement cases. In the pharmaceutical and life sciences fields, Mr. Faulkner has represented parties in trade secret, antitrust, and patent infringement actions involving branded pharmaceuticals such as Crestor®, Paxil®, Prozac®, Doribax®, Zymar®, Engerix-B®, Infranrix®, Veralix®, Adenoscan®, Adenocard®, and AmBisome®. 

​

In other fields, York’s litigation experience includes matters filed in federal and state courts as well as the International Trade Commission, involving medical devices, automobile parts, semiconductor design and production, steel manufacturing, commercial jet engine design, genetically modified crops, vehicle crash sensor control units, digital image processing, iris scanning and identification, liquid crystal displays, long-haul fiber optic routing and switching, and microprocessor instruction sets.

​

York has a global practice. He has lived and worked periodically in Japan since 1984 in such places as Tokyo, Nagano Prefecture, Tochigi Prefecture, and Saitama Prefecture. He speaks and reads Japanese. York frequently lectures to Japanese audiences on legal and economic issues affecting Japanese companies and their global businesses; counsels clients on strategic IP development, litigation, and transactions; and participates in local professional associations such as the Licensing Executive Society of Japan.

 

York has extensive experience in litigation involving Japanese parties and routinely works in collaboration with local Japanese bengoshi and benrishi to reduce the burden of U.S. litigation on Japanese clients. He has managed complex global litigation requiring coordination of U.S. litigation strategy with co-pending litigation in Japan, South Korea, China, Australia, Europe, and Canada.

​

York has been recognized on Managing Intellectual Property’s “IP Stars” list and has been recognized as a leading trade secret and copyright litigator by The Legal 500 U.S.

 

York is also a co-author on the leading Japanese-language publication on FDA approvals and Hatch-Waxman drug and biosimilar litigation. See FDA Pharmaceutical Regulation and Drug Patent Litigation - A Guidebook for U.S. Drug Development (Research Institute of Economy, Trade, and Industry); FDAの薬事規制と医薬品特許権侵害訴訟～米国創薬ガイド (現代産業選書―知的財産実務シリーズ、経済産業調査会).